Far East Bio-Tec Co., Ltd.

NT$38.65As of Sun 8 Nov 2026, 12:00 UTC

TPEx:6886Consumer Def

Country Taiwan

PE (Fwd) 25.88

TSR 3Y CAGR (3.76%)

Div yield —

ROE 10.89%

Packaged Foods

Beta (5Y) —

PE TTM 22.58

TSR TTM (7.86%)

Mkt cap NT$1.352B

ROIC 20.17%

SE Grade™

Value

Quality

Moat

1Y Price

Reference

NT$40

3.63%

16.94%

Price below Reference Value

TTM

FYE 31 Dec TWD

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

401.7

RevenueNT$M

—

379.7

306.2

387.7

401.7

392.6

1.89%

—

3.60

Revenue growth%

—

(19.37)

26.63

3.60

(2.25)

3.60

—

50.50

Gross margin%

—

56.54

46.46

48.21

50.50

49.87

49.35

—

17.08

Operating margin%

—

28.81

9.32

16.54

17.08

15.86

16.81

—

14.93

Net margin%

—

23.88

8.95

13.54

14.93

14.00

14.24

—

22.58

P/E ratio (avg)x

—

54.60

26.50

25.23

24.64

26.50

—

16.58

EV/EBITx

—

43.15

18.47

18.93

18.60

18.93

—

(0.85)

FCF yield (avg)%

—

(1.18)

(0.73)

(0.76)

(1.39)

(0.76)

—

(2.87)

FCF margin%

—

25.17

(5.76)

(2.63)

(2.87)

(4.80)

(2.75)

—

(0.192)

FCF / Net incomex

—

1.054

(0.644)

(0.194)

(0.192)

(0.343)

(0.193)

—

20.17

ROIC%

—

59.73

13.99

24.10

20.17

15.19

22.13

—

10.89

Return on equity%

—

21.01

5.95

10.47

10.89

8.93

10.68

—

8.55

Return on assets%

—

16.61

4.81

8.19

8.55

7.26

8.37

—

1.71

EPSNT$

—

2.98

0.83

1.63

1.71

1.57

(16.90%)

—

5.24

EPS growth%

—

(72.32)

96.99

5.24

(8.36)

5.24

—

16.78

Bookvalue per shNT$

—

14.19

14.73

15.92

16.78

18.34

5.73%

—

(0.33)

FCF per shareNT$

—

3.14

(0.53)

(0.32)

(0.33)

(0.54)

—

Dividend per shNT$

—

Div yield (avg)%

—

Payout ratio%

—

34.99

Shares (diluted)M

—

30.40

33.18

32.28

35.04

◌35.04

4.85%

—

(8.58)

Buyback yield%

—

(9.14)

2.72

(8.58)

◌—

(8.58)

—

0.097

D/E ratiox

—

0.110

0.077

0.134

0.097

0.088

0.103

—

1.138

Enterprise valueNT$B

—

1.232

1.185

1.298

1.158

2.66%

—

10.83

LT debtNT$M

—

25.83

20.83

15.83

10.83

(25.15%)

—

Peers (US$40.77M)

Cap (US$)

Lian Fa International…

44.74M

15.41x

DaBomb Protein Biotech…

36.72M

—

Jia Jie Biomedical Co.…

36.22M

387.8x

Premium Snacks Nordic…

40.84M

14.34x

Capital

TTM

10Y

Leveragex

(2.370)

(2.422)

EBIT/Intx

61.74

57.42

Own earn%

—

Sh yield%

(8.58)

Owners

Insiders/Inst%

18.48

3.11

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

4/4

Revenue growth years

2/3

EPS growth years

2/3

Dividend streakyrs

Op margin range%

9–29

$1 testx

—

Incr. ROIC%

−22

Far East Bio-Tec Co., Ltd. manufactures and sells organic chlorella, spirulina, and dietary supplements. It also offers nutraceuticals/nutritional supplements, immune booster products, antiviral sprays, and pet supplements. The company was founded in 1976 and is based in Taipei, Taiwan.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

NT$401.7M

1.89%

1.00×

Cost of revenue

NT$198.9M

6.41%

1.14×

Operating expenses

NT$134.2M

8.44%

1.21×

Asset mix

Trend

Other

61.30%

Cash and investments

38.70%

Reinvestment returns

No breakdown available